Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison Adv Ther
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling CANCER COMMUN
First-line treatment of multiple myeloma in both transplant and non-transplant candidates EXPERT REV ANTICANC
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials Blood Adv
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature TRANSPL CELL THER
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI Eur J Haematol
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease Nat Commun
Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease Rev Esp Patol